EP2739645
ENDOGLIN-SPECIFIC ANTIBODY FOR USE IN A METHOD OF TREATING HEART FAILURE AND RELATED CONDITIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.7.2012EP published:
19.12.2018EP application number:
12820719.8
EPO information:
European Patent Register
Max expiry date:
30.7.2032
Title:
ENDOGLIN-SPECIFIC ANTIBODY FOR USE IN A METHOD OF TREATING HEART FAILURE AND RELATED CONDITIONS
Timeline
Today
31.7.2012EP application
19.12.2018EP Publication
Owner
Name:
Tufts Medical Center, Inc.Address:
750 Washington Street, 02111, Boston, MA, US
Inventor
Name:
KAPUR, Navin, K.Address:
Hanover, MA, US
Name:
KARAS, Richard, H.Address:
Franklin, MA, US
Priority
Number:
201161513930 PDate:
1.8.2011Country:
US
Number:
201161578477 PDate:
21.12.2011Country:
US
Classification
Categories:
A61K 38/17, A61K 38/18, A61K 39/395, A61K 31/713, A61K 31/7088, C07K 16/28, A61P 9/00, A61P 9/04, A61P 43/00, C07K 16/22